Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
2020 ◽
Vol 19
◽
pp. 232595821989953
Keyword(s):
There is no guideline concerning choice of antiretroviral therapy (ART) for HIV-infected patients after unplanned interruption. We conducted a retrospective cohort study of HIV-infected patients reintroduced to first-line ART after having unplanned interruption for at least 1 month. Viral load was evaluated at 6 to 18 months after the reintroduction. There were 100 patients included in our study, and 55 of them achieved virological success. History of single interruption (adjusted odds ratio [aOR] 5.51%, 95% confidence interval [CI] 1.82-16.68, P = .003) and CD4 count ≥200 cell/mm3 at the time of reintroduction (aOR 4.33, 95% CI 1.14-16.39, P = .031) increased likelihood to achieve virological success.
2019 ◽
2018 ◽
Vol 08
(02)
◽
pp. e89-e94
◽
2015 ◽
Vol 27
(2)
◽
pp. 118-126
◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 29
(1)
◽
Keyword(s):
2020 ◽
Vol 19
◽
pp. 232595822091926